150
Participants
Start Date
October 15, 2024
Primary Completion Date
December 30, 2024
Study Completion Date
March 31, 2025
Diabetes Treatment
Lucie™ is an innovative medical device for measurement by bio-impedancemetry. It has been developed specifically to meet medical needs in nephrology. The aim of the study is to compare its performance with a reference device validated in nephrology nephrology, the Body Composition Monitor® (BCM) from Fresenius.
Home Habilis
INDUSTRY